Status:
UNKNOWN
Study of Blood and Tissue Samples From Patients With Larynx Cancer, Pharynx Cancer, or Oral Cavity Cancer
Lead Sponsor:
Centre Oscar Lambret
Conditions:
Head and Neck Cancer
Eligibility:
All Genders
15+ years
Brief Summary
RATIONALE: Studying samples of blood and tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer....
Detailed Description
OBJECTIVES: Primary * Characterize, morphologically and molecularly, squamous cell carcinoma of the larynx, pharynx, or oral cavity in patients without high-risk factors, such as alcohol consumption...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Histologically confirmed squamous cell carcinoma of the larynx, pharynx, or oral cavity
- No risk factors of alcohol consumption, smoking, or occupational hazards such as asbestos, hydrocarbons, paints, nickel, stone dust, or wood dust.
- Must be a life-time non-smoker, not a former smoker
- Measurable disease by RECIST criteria
- PATIENT CHARACTERISTICS:
- WHO performance status 0-1
- No other serious concomitant medical conditions precluding general anesthesia
- No psychological, familial, social, or geographical reasons that would preclude follow up
- PRIOR CONCURRENT THERAPY:
- Not specified
Exclusion
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00963326
Start Date
June 1 2008
Last Update
February 28 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Oscar Lambret
Lille, France, 59020